2026 T1D Breakthroughs: Gene Editing, CAR-T, & Cell Therapies Race for a Cure
As of mid-2026, Type 1 diabetes (T1D) research has entered a pivotal phase, with gene-edited islet therapies, in vivo CAR-T cell treatments, and bioengineered insulin-producing implants advancing toward regulatory approval. ... Read More